Back
    Back

    Scientists of the IEM CAS presented at the PragueONCO 2025 conference: Personalized medicine and the new approaches to cancer diagnosis and treatment

    ConferenceProfessional Events Published on 03. 02. 2025 Reading time Reading time: 2 minutes
    Group photo of IEM CAS female scientists in front of the presentation wall with the PragueONCO conference graphics

    On 29-31 January 2025, the PragueONCO conference (opens in new window), one of the most significant professional educational events in the Czech Republic, took place in the Clarion Hotel Prague Congress Centre. This meeting connects leading specialists in the fields of oncology, molecular biology and personalised medicine to discuss the latest trends in cancer research and therapy.

    The programme also included poster presentations by scientists from the IEM CAS, namely from the Department of Molecular Biology of Cancer, who presented their latest studies on innovative cancer diagnosis and treatment approaches. The main topics included the use of biomarkers for early detection of cancer or new strategies for targeted therapy.

    We would like to thank our colleagues for the excellent representation of the IEM CAS and wish them much success in their future research!

    Speakers

    • Safaa Andarawi / Senescent cells in colorectal cancer in relation to DNA repair capacity and chemotherapy resistance
    • Kateřina Balounová / Tert enzymatic activity and expression as prognostic biomarkers in metastatic colorectal cancer
    • Natálie Danešová / Changes in mitochondrial DNA in colorectal cancer patients
    • Keti Kharazishvili / Liquid biopsy as a diagnostic tool for early detection of pancreatic ductal adenocarcinoma
    • Michal Kroupa / Patterns of chromosomal instability and epigenetic alterations in colorectal cancer progression: from high-grade dysplasia to liver metastasis
    • Saba Selvi / Identification of molecular and epigenetic candidates elucidating therapy resistance in colorectal cancer
    • Anusha Uttarilli / Relative telomere length measurement in 5371 samples, including colorectal carcinoma adenoma patients and healthy controls from Austria n cohort corsa study
    • Anna Valíčková / Mutational profile of precancerous stages of colorectal cancer
    • Klára Vokáčová / Clinical and technical aspects of circulating tumour DNA as a predictive marker for new therapeutic approaches in locally advanced rectal cancer
    • Veronika Vymetálková / Non-invasive detection of circulating mRNA markers in colorectal diseases – part II.